Penserra Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,215
| Closed | -$32K | – | 1539 |
|
|
2021
Q3 | $32K | Buy |
1,215
+10
| +0.8% | +$263 | ﹤0.01% | 1171 |
|
|
2021
Q2 | $37K | Buy |
1,205
+15
| +1% | +$461 | ﹤0.01% | 1068 |
|
|
2021
Q1 | $31K | Sell |
1,190
-20
| -2% | -$521 | ﹤0.01% | 902 |
|
|
2020
Q4 | $30K | Buy |
1,210
+758
| +168% | +$18.8K | ﹤0.01% | 781 |
|
|
2020
Q3 | $9K | Buy |
+452
| New | +$9K | ﹤0.01% | 826 |
|
|
2018
Q3 | – | Sell |
-244,371
| Closed | -$29M | – | 745 |
|
|
2018
Q2 | $29M | Buy |
+244,371
| New | +$29M | 1.83% | 13 |
|